Thymosin Alpha-1 (5 mg)
Thymosin Alpha-1 (Thymalfasin) is an N-terminally acetylated 28-amino acid acidic thymic peptide investigated extensively in Toll-like receptor (TLR2/TLR9) activation, dendritic cell maturation, and T-cell immunology.
Scientific Profile & Research Key Points: Thymosin Alpha-1
Thymosin Alpha-1 (Thymalfasin) is an N-terminally acetylated 28-amino acid acidic thymic peptide investigated extensively in Toll-like receptor (TLR2/TLR9) activation, dendritic cell maturation, and T-cell immunology.
Active Batch Release Specifications (Lot SL-2026-164)
Analytical release verification for current Thymosin Alpha-1 (5 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-164 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water (acidic peptide; dissolves readily at neutral pH)
Temperature & Stability
Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 28 days.
Thymosin Alpha-1 — Technical Questions & Answers
What is the molar concentration when reconstituting Thymosin Alpha-1 (5 mg) in 2.0 mL?
Reconstituting the full 5 mg vial of Thymosin Alpha-1 (MW 3108.28 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.80 mM (804 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does Thymosin Alpha-1's counterion stoichiometry affect assay mass calculations?
Thymosin Alpha-1 (CAS 62304-98-7, formula C129H215N33O55) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify Thymosin Alpha-1 Lot SL-2026-164 and what pathway does it target?
Lot SL-2026-164 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 3108.28 g/mol. In preclinical literature, Thymosin Alpha-1 targets TLR2 / TLR9 dendritic cell maturation & Th1 cytokine signaling (Romani L. et al., Ann N Y Acad Sci (2012) — Thymosin α1 activation of TLR9/IDO dendritic pathways (PMID: 23050819)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
TB-500 (Thymosin β4): Actin Regulation, Cell Motility, and Angiogenesis in Wound Repair
A biochemical review of Thymosin Beta-4 and its synthetic sequence TB-500. G-actin monomer sequestering, cell migration, down-regulation of inflammation, and HPLC analysis.
KPV Tripeptide (Lys-Pro-Val): C-Terminal Alpha-MSH Chemistry, NF-κB Inactivation, and Gut Mucosal Integrity
A biochemical review of the KPV tripeptide (Lys-Pro-Val). Transport via PepT1, nuclear translocation blockade of NF-κB p65, cytokine reduction (TNF-α, IL-6), and mucosal barrier restoration assays.
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.